Displaying 1 - 12 of 33

Display:

12 24 48

Metabolism, Alcohol & Toxicity

8

Sanofi: Reducing the burden of liver disease - new evidence revealed - EASL Congress 2024

View

Metabolism, Alcohol & Toxicity

8

Sanofi: Reducing the burden of liver disease - new evidence revealed - EASL Congress 2024

View

Metabolism, Alcohol & Toxicity

8

Sanofi: Reducing the burden of liver disease - new evidence revealed - EASL Congress 2024

View

Metabolism, Alcohol & Toxicity

8

Sanofi: Reducing the burden of liver disease - new evidence revealed - EASL Congress 2024

View

Metabolism, Alcohol & Toxicity

8

Sanofi: Reducing the burden of liver disease - new evidence revealed - EASL Congress 2024

View

Metabolism, Alcohol & Toxicity

8

Sanofi: Reducing the burden of liver disease - new evidence revealed - EASL Congress 2024

View

Metabolism, Alcohol & Toxicity

8

Sanofi: Reducing the burden of liver disease - new evidence revealed - EASL Congress 2024

View

Metabolism, Alcohol & Toxicity

8

Sanofi: Reducing the burden of liver disease - new evidence revealed - EASL Congress 2024

View

Metabolism, Alcohol & Toxicity

6

Opella: MASLD: Early screening, Treatment Strategies, and Quality of Life – Insights from New Clinical Evidence - EASL SLD Summit 2025

View

Metabolism, Alcohol & Toxicity

6

Opella: MASLD: Early screening, Treatment Strategies, and Quality of Life – Insights from New Clinical Evidence - EASL SLD Summit 2025

View

Metabolism, Alcohol & Toxicity

6

Opella: MASLD: Early screening, Treatment Strategies, and Quality of Life – Insights from New Clinical Evidence - EASL SLD Summit 2025

View

Metabolism, Alcohol & Toxicity

6

Opella: MASLD: Early screening, Treatment Strategies, and Quality of Life – Insights from New Clinical Evidence - EASL SLD Summit 2025

View

Displaying 1 - 12 of 33

Display:

12 24 48